MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
BRO HOLD REF $69 PW TARGET $63 (-10% vs spot · 12m PWEV) -9% Single-name research · 8 July 2026
Equity ResearchFinancials · Insurance Brokers
BRO

Brown & Brown Inc (BRO)

HOLD. 12-month probability-weighted target $63 (-9% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $58 (-16% vs spot · triangulated FV)
Reference
$69
Close · 8 July 2026
PW Target
$63 (-10% vs spot · 12m PWEV) -9%
Probability-weighted
Horizon
12 mo
MCH Advisory
$58 (-16% vs spot · triangulated FV)
Fair value
$63 (-10% vs spot · 12m PWEV)
Scenario PWEV
14.3x
Forward P/E
$22B
Market cap
$54–$110
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · mature cash generator · conviction: medium

Metric Value
Current Price $69
Triangulated Fair Value $58 (-16% vs spot · triangulated FV)
12-mo Scenario PWEV $63 (-10% vs spot · 12m PWEV)
Forward P/E 14.3x
Market Cap $22B
52-Week Range $54–$110

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction mature cash generator · medium
Triangulated fair value $58 (-16% vs spot · triangulated FV)
12-mo scenario PWEV $63 (-10% vs spot · 12m PWEV)
Next catalyst 2026-07-27 — Quarterly earnings
Primary thesis-break Total revenue growth, year-on-year (as reported) < 0.035 (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies -10% vs spot
  • Monte Carlo median implies -18% vs spot
  • DCF fair value implies -28% vs spot — but this is terminal-value sensitive (exit-multiple $50 vs Gordon $84, 68% apart), so it carries less weight
  • Bear case (Structural — Soft-Market / Commission Pressure) downside is -53% vs spot
  • Net: reward/risk of 0.3× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $64.15 (27 June 2026) Brown & Brown trades on 13.3x forward earnings against a broker peer median of 16.1x, and 42% below its 52-week high of $110.11. The market is pricing a roll-up that levered to $7.06bn of net debt near the top of the commercial P&C pricing cycle, just as that cycle softens. The engine partly agrees. The probability-weighted target of $62.92 sits 1.9% below spot; the capex-bridge DCF anchors at $49.97 and the Monte Carlo median at $56.96, with 74% of simulated variance carried by the multiple rather than the business drivers. The Gordon terminal ($83.91) and the peer P/E cross-read ($77.85) argue the discount is overdone, but they do not carry the blend. HOLD follows: the anchors bracket spot rather than clearing it. The most damaging risk is a genuine soft market meeting the acquisition debt — organic growth and contingent commissions fade exactly when the interest bill is fixed.

The dashboard below is the whole argument on one page: spot ($69) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $69 spot from $50 to $78 — stretched — spot sits above the skeptical blend.
Integrated dashboard. The five valuation anchors bracket the $69 spot from $50 to $78 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The steelman bear is mechanical, not sentimental. Commercial P&C pricing has compounded for years; when the cycle turns, broker commissions fall with premium rates while expense bases built for a hard market do not. Brown & Brown's model amplifies the turn: contingent and supplemental commissions are geared to carrier profitability, and the roll-up now carries $7.06bn of net debt from the 2025 debt-funded acquisition, so a falling EBITDA meets a fixed interest bill. In that state organic growth goes negative, the operating margin compresses towards 24%, and the market re-rates the acquisition-driven model to a single-digit earnings multiple. The structural scenario's $31.99 target, below the 52-week low of $53.81, is the honest price of that combination — and it carries a 20% probability.

Key Debate

P/E Multiple explains 74% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.25 vs analyst floor +0.00 → delta +0.25 (n=43 mgmt / 34 Q&A; 23th pctile across the S&P book, z -0.9).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

Quarter Mgmt Analyst Delta
2026Q1 +0.25 +0.00 +0.25
2025Q4 +0.24 +0.10 +0.14
2025Q3 +0.38 +0.24 +0.14
2025Q2 +0.44 +0.18 +0.26

News (last 365d, 1000 articles): avg ticker sentiment +0.12 (bullish 18% / bearish 6%)

Scenario Analysis

The tree runs from a structural 'Structural — Soft-Market / Commission Pressure' downside ($32) to a 'Bull — Defensive Re-Rate' bull case ($98); the probability-weighted blend (PWEV $63) is -10% versus spot.

Scenario Probability Target Return vs spot
Structural — Soft-Market / Commission Pressure 20% $32 -53%
Economic / Exposure Recession 17% $52 -25%
Base — Organic + Pricing + M&A 35% $65 -7%
Growth — Specialty / International / Consolidation 20% $84 +21%
Bull — Defensive Re-Rate 8% $98 +42%
Probability-Weighted (PWEV) $63 -10%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Soft-Market / Commission Pressure (20%, $32). Structural impairment — soft-market / commission pressure: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 31.99; probability: 0.2.
  • Economic / Exposure Recession (17%, $52). Cyclical downturn — brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) weakens for 1–2 years before normalising. Drivers — implied_target: 51.74; probability: 0.17.
  • Base — Organic + Pricing + M&A (35%, $65). Mid-cycle — normalised brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk); disciplined capital allocation; steady returns. Drivers — implied_target: 66.17; probability: 0.35.
  • Growth — Specialty / International / Consolidation (20%, $84). Upside — specialty / international / consolidation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 83.54; probability: 0.2.
  • Bull — Defensive Re-Rate (8%, $98). Upside tail — sustained tight conditions or a structural re-rate on specialty / international / consolidation. Drivers — implied_target: 98.26; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $69 spot; PWEV $63 (-10% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $32–$98)
Five-scenario tree. Probability-weighted targets around the $69 spot; PWEV $63 (-10% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $32–$98)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $57 -18%
Peer P/E re-rate multiple $78 +12%
Peer EV/Revenue re-rate multiple $58 -16%
Scenario PWEV multiple $63 -10%
DCF (5-year + terminal) cash flow + terminal × $50 -28%
Triangulated (weighted) $58 -16%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $57 + scenario PWEV $63, ≈ spot); the weighted blend $58 (-16%) sits below it because the cash-flow DCF ($50) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $57 and 27% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (74% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median $57; P(price > current) 27%. P10–P90: $35–$84.
Monte Carlo distribution. Median $57; P(price > current) 27%. P10–P90: $35–$84.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.0%, 11x terminal FCF multiple → $50. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 8.0%, 11x terminal → $50.
Independent DCF. WACC 8.0%, 11x terminal → $50.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 16.085x) implies $78. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 16.085x → $78; EV/Rev re-rate → $58.
Cross-sectional peer benchmarking. Peer-median fwd P/E 16.085x → $78; EV/Rev re-rate → $58.

Across all anchors the spread is 48% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Insurance Brokerage $6.3B 100% 7% 30% $1.9B 13x 2% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk)
net_debt_or_cash_b -7.06

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.02
div_yield 0.0102

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside soft-market / commission pressure
upside specialty / international / consolidation

Industry Context — Financials — Insurance Services

This name sits in the Financials — Insurance Services as a insurance_broker. brokerage organic growth + P&C pricing cycle + bolt-on M&A (fee/commission, no underwriting risk) Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: MRSH (insurance_broker) · AON (insurance_broker) · AJG (insurance_broker) · WTW (insurance_broker) · BRO (insurance_broker) · ERIE (insurance_broker)

Shared state Capex path House view This name implies
Soft-Market / Commission Pressure 37% 37%
Mid-Cycle — Organic + Pricing + M&A 35% 35%
Upside — Specialty / Consolidation 28% 28%

Mapping note: name-level 'Structural — Soft-Market / Commission Pressure' (20%) + 'Economic / Exposure Recession' (17%) map to cluster Soft-Market / Commission Pressure (37%); name-level 'Growth — Specialty / International / Consolidation' (20%) + 'Bull — Defensive Re-Rate' (8%) map to cluster Upside — Specialty / Consolidation (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Soft-Market / Commission Pressure () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The fin_insurance_services cycle is the shared macro driver. Driver — brokerage organic growth + P&C pricing cycle + bolt-on M&A (no underwriting risk) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $7B $2B $0B $0B $2B $1B
FY+2 $7B $2B $0B $0B $2B $1B
FY+3 $8B $2B $0B $0B $2B $2B
FY+4 $8B $3B $0B $0B $2B $1B
FY+5 $8B $3B $0B $0B $2B $1B
Terminal $2B × 11x $16B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 2% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.0% · Σ PV(FCF) $7B + PV(terminal) $16B = EV $23B; + net cash → equity $16B ÷ diluted shares 0.32B = $50/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $84/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 117% vs WACC 8% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
MRSH 3.598x 15.67x 7% 24%
AON 4.779x 17.15x 7% 36%
AJG 4.587x 16.5x 7% 28%
WTW 3.006x 13.79x 7% 20%
Median 4.092499999999999x 16.085x

Peer-median fwd P/E → $78; EV/Rev → $58.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $50 41% $21
Scenario PWEV $63 29% $18
Monte Carlo median $57 18% $10
Peer P/E $78 12% $9
Triangulated 100% $58

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 7.7x 9.3x 11.0x 12.6x 14.3x
6% $40 $48 $56 $64 $72
7% $37 $45 $53 $60 $68
8% $35 $42 $50 $57 $64
9% $33 $40 $47 $54 $61
10% $31 $37 $44 $51 $58

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $36 $38 $41 $44 $47
-1.5pp $39 $42 $45 $49 $52
+0.0pp $43 $47 $50 $53 $56
+1.5pp $47 $51 $54 $58 $61
+3.0pp $52 $55 $59 $63 $67

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Revenue CAGR ±3pp $41 $59 $18
Terminal × ±15% $42 $57 $15
Op margin ±3pp $43 $56 $13
WACC ±1pp $47 $53 $6
Capex intensity ±15% $49 $50 $1

Company lever — SoP/share vs Insurance Brokerage multiple (AI re-rating) (base 13x)

Multiple 9.1x 11.0x 13.0x 14.9x 16.9x
SoP/share $157 $194 $233 $270 $310

Consensus & Market Expectations

Reference Value
Street target (mean) $72 (+5% vs spot · street)
House target $63 (-13.1% vs street)
Sell-side coverage 19 analysts (SB 2 / B 3 / H 14 / S 0 / SS 0; net score 0.18)
Consensus FY EPS $4.87; house in-line (-0.6%)
Consensus FY revenue $7.4B; house below (-9.5%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $6.8B — levered
Net debt / EBITDA 2.75x
Interest coverage (EBIT / interest) 5.6x
Current ratio 1.04x
Lease obligations $0.3B
Cash & ST investments $1.1B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $1.4B
Buybacks / dividends $0.1B / $0.2B
Total shareholder yield 1.3%
Payout as % of FCF 21.3%
Reinvestment (capex / OCF) 4.7%
SBC as % of FCF 6.7%
Allocation stance reinvesting

Free-Cash-Flow Quality

Metric Value
FCF margin 21.9%
FCF conversion (FCF / net income) 129.5%
FCF yield 6.2%
Capex intensity (capex / revenue) 1.1%
FCF − SBC (diagnostic) $1.3B
Capex split (maint / growth) 75% / 25% — Capital-light broker (~2% capex/rev); PP&E is minimal. The dominant growth spend is acquisition, funded off balance sheet and not in this line. On-P&L capex is largely maintenance IT/office; growth share reflects platform/technology and producer tooling.

Accounting quality: SBC 1.5% of revenue; cash conversion (OCF/NI) 136% — cash-backed.

Catalyst Calendar

  • 2026-07-27 (~19d) — Quarterly earnings — est. EPS $1.09 (AV EARNINGS_CALENDAR)
  • 2026-09-30 (~84d) — Large-scale bolt-on / platform acquisition close (authored)
  • 2026-10-27 (~111d) — Investor day / long-term organic-growth and margin framework (authored)
  • 2027-01-15 (~191d) — January 1 P&C commercial renewal pricing read (authored)

Forecast Track Record

  • EPS surprise: beat 87.5% of the last 8 quarters; average surprise +5.3%.

Competitive Moat

Narrow moat. Insurance broking is capital-light, sticky and high-retention (fee/commission, no underwriting risk) - but the moat is narrow: it rests on local relationships and acquisition sourcing, not a structural barrier, and larger brokers (AON, MMC, WTW) compete for the same accounts. The premium is really an M&A-compounding multiple. Falsifiable: if organic growth normalizes to low-single-digits as the P&C pricing cycle softens and bolt-on multiples rise, the ~13x it trades at is not justified above it and should not re-rate toward the 16x broker peer median.

Moat sources:

  • High client-retention and renewal economics (~90%+) in commercial P&C mid-market
  • Decentralized, incentive-aligned producer culture and local relationships
  • Disciplined bolt-on M&A machine - a process moat, not a structural one
  • No underwriting/balance-sheet risk - capital-light recurring-commission model
Issue Probability Valuation sensitivity Horizon
Broker-compensation / contingent-commission disclosure scrutiny low (~20%) low - modest fee-transparency risk; ~2-3% of FV 12-24m
Interest-rate path affecting fiduciary-investment income and deal-financing cost on net debt medium (~40%) medium - float income + leverage cost; ~4-5% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Soft-Market / Commission Pressure P&C pricing enters a multi-year soft market; commission rates and exposure units compress; bolt-on multiples inflate. Organic growth and M&A accretion fade together while $7bn net debt weighs on returns.
Economic / Exposure Recession Recession shrinks insurable exposure units (payroll, revenue, property values), cutting the commission base. Exposure contraction compounds soft pricing, pushing organic growth negative.
Base — Organic + Pricing + M&A Moderate P&C pricing, mid-single-digit organic growth and a steady bolt-on cadence at disciplined multiples. Leverage near cycle top constrains M&A firepower if credit tightens.
Growth — Specialty / International / Consolidation Firm P&C pricing plus specialty/international expansion and continued industry consolidation. Rising acquisition multiples erode the returns on the M&A engine.
Bull — Defensive Re-Rate Market rewards the recurring, recession-resilient fee model with a defensive re-rate. Re-rate unwinds if the pricing cycle turns and organic growth disappoints.

What the Market Is Pricing In

At the current price, the market pays 14.2× forward EPS, vs the house DCF terminal 11.0×, and a peer median 16.085×. The house DCF sits 28% below spot, so the market is pricing in more than the house case — roughly 2.3pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily FCF-driven.

Metric Consensus House Importance
Revenue 7.4 6.7 High
EPS 4.9 4.8 Medium
Target price 72.4 62.9 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
MRSH 15.67× 7% 24% direct 100%
AON 17.15× 7% 36% direct 100%
AJG 16.5× 7% 28% direct 100%
WTW 13.79× 7% 20% direct 100%

Quality-weighted forward P/E: 15.8× (simple median 16.085×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $54–$110, centre $77 (+11% vs spot); spot sits at the 27th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $58 (-16% vs spot · triangulated FV)
Downside to bear case (Structural — Soft-Market / Commission Pressure) $32 (-53% vs spot · bear scenario)
Reward/risk ratio 0.3×
Margin of safety (FV vs spot) -19%
P(price > spot) — Monte Carlo 27%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Defensive Re-Rate): $98.

Assumption Register

Assumption Value Used in Source
WACC 8.0% DCF discount rate estimate (CAPM)
Terminal multiple 11× DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (18.0); Terminal × ±15% (15.0); Op margin ±3pp (13.0); WACC ±1pp (6.0); Capex intensity ±15% (1.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $6.3B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $6.7B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $4.8676 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.323B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $6.839B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 8.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple 11× house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-27
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 11×, FY+5 revenue $8B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Total revenue growth, year-on-year (as reported) < 0.035 (2 consecutive prints → Soft-Market / Commission Pressure). The base path assumes 7% total growth (organic plus bolt-on M&A); the recession path assumes 0%. The 3.5% midpoint separates a slow patch from the bear mechanism taking hold.
  • Operating margin, quarterly annualised < 0.286 (2 consecutive prints → Soft-Market / Commission Pressure). Midpoint of the base margin (30.2%) and the recession margin (27.0%). Two prints below it show commission operating leverage working in reverse — the expense base was built for a hard market.
  • US commercial P&C composite renewal rate change (CIAB quarterly survey) < 0.0 (2 consecutive prints → Soft-Market / Commission Pressure). Commission revenue is geared to premium rates. Two consecutive quarters of negative composite renewal pricing marks a broad soft market rather than line-specific softening, and precedes the revenue effect by two to three quarters.
  • Net debt / EBITDA > 3.5 (2 consecutive prints → Soft-Market / Commission Pressure). Net debt stands at $7.06bn after the 2025 debt-funded acquisition, roughly 3.1x EBITDA implied by the 12.16x EV/EBITDA on $27.65bn EV. A move above 3.5x means deleveraging has stalled or EBITDA is falling — the mechanism that converts a cyclical soft market into a balance-sheet problem.
  • Diluted EPS, trailing four quarters annualised < 4.57 (2 consecutive prints → Soft-Market / Commission Pressure). Midpoint of the computed base-scenario EPS ($4.98) and the recession-scenario EPS ($4.16) on 0.323bn diluted shares. Two prints tracking below it mean the base path is no longer live and the probability weights should shift bear-ward.

Fact / Inference / Speculation

  • FACT: Spot $69; 52-week range $54–$110; engine rating HOLD; base-case target $63 (-9%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
  • INFERENCE: Triangulated FV $58 (-16% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Recommendation: HOLD

Balanced: triangulated fair value $58 (-16% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.